Advanced Search


Study ID Status Title Patient Level Data
204516 Completed An Exploratory Study to Assess Two Accelerated Models of Barrier Repair
204521 Not yet recruiting Meta-analysis of Arnuity (FF) studies FFA109685 & FFA112059 Direct comparison of FF100 QD and FP 250 BD for Trough FEV1
204524 Active, Not Recruiting Nucala® Subcutaneous Injection Special Drug Use Investigation (Long-Term)
204645 Recruiting Seasonal Allergic Rhinitis Symptom Severity Observational Study
204646 Completed Bioequivalence Study of Dutasteride Capsules-An evaluation of the bioequivalence of dutasteride capsule manufactured at GSK compared to dutasteride capsule manufactured at Catalent in healthy Japanese male subjects Study Listed on
204653 Recruiting A phase I, open-label, dose escalation study to investigate the safety, pharmacokinetics, pharmacodynamics and clinical activity of GSK3326595 in subjects with solid tumors and non-Hodgkin’s lymphoma
204654 Recruiting Protocol to Characterize Severe Asthma Patient Experience of Treatment Benefit with an anti-IL5 with Clinical Trial Exit Interviews
204661 Completed PGx7612: Pharmacogenetic investigation of the association of the ADRB2 rare variant, Thr164Ile with severe asthma exacerbation
204662 Completed A Phase I, Open-label, Single-dose Study to Investigate the Pharmacokinetics, Safety and Tolerability of abacavir/dolutegravir/lamivudine fixed-dose combination tablets in Healthy Japanese Subjects
204663 Completed An exploratory study to assess the effect of topical application of Iodex® balm on local surface temperature using infra red thermal imaging technique
204664 Completed Meta-Analysis in sponsored studies MEA112997, MEA115588, and MEA115575 and a proof of concept investigator sponsored study CRT110184 of Mepolizumab in Severe Asthma
204673 Withdrawn A Phase I/II Open-Label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK525762 Plus Trametinib in Subjects with Small Cell Lung Cancer and Ras-Mutated Solid Tumors
204674 Recruiting An open label, multi-centre, post marketing surveillance (PMS) to monitor the safety and effectiveness of RELVAR administered in Korean subjects in usual practice.
204675 Recruiting Evaluating the effectiveness of the revised alli® pack information in helping pharmacy staff within the EU supply alli® appropriately.
204676 Completed A Study to Evaluate the Effects of Protein Supplementation in Attenuating the Decline in Performance Following Strenuous Concurrent Exercise
204678 Completed A single centre, open-label, parallel-group, single oral dose study to evaluate the pharmacokinetics, safety and tolerability of Pyrimethamine in healthy Japanese and Caucasian male subjects
204682 Completed An Open-label Extension to Study 200952 to Evaluate the Long-term Safety, Tolerability and Pharmacodynamics of Albiglutide Liquid Drug Product in Subjects with Type 2 Diabetes Mellitus
204685 Completed A 2-part randomized, double-blind (sponsor-unblinded), placebo-controlled, ascending dose and parallel group study of TLR4 agonist (GSK1795091) administered to healthy subjects
204687 Recruiting Assessment of safety of GlaxoSmithKline (GSK) Vaccines’ quadrivalent seasonal influenza vaccine, Fluarix Tetra when administered according to the approved Prescribing Information in Korea.
204691 Recruiting A Phase I Open Label Study of GSK3359609 Administered Alone and in Combination with Anticancer Agents in Subjects with Selected Advanced Solid Tumors
204697 Recruiting A phase IB open-label, dose escalation and expansion study to investigate the safety, pharmacokinetics, pharmacodynamics and clinical activity of GSK525762 in combination with androgen deprivation therapy and other agents in subjects with castrate-resistant prostate cancer (CRPC)
204699 Completed A randomized double-blind (sponsor unblind) placebo controlled study in healthy subjects to evaluate: safety, tolerability, pharmacokinetics, and pharmacodynamics of the repeat doses of GSK2881078, the Selective Androgen Receptor Modulator with an open label dosing arm to evaluate the effect of CYP3A4 inhibition on pharmacokinetics of GSK2881078
204710 Not yet recruiting A Multinational, Single Arm, Observational Study to Evaluate the Real-world Effectiveness and Pattern of Use of Mepolizumab in Patients with Severe Eosinophilic Asthma (204710)
204715 Recruiting A study of single doses to evaluate the safety, tolerability, pharmacokinetics and target engagement of nebulised GSK3008348 in idiopathic pulmonary fibrosis patients, using positron emission tomography (PET) imaging
204716 Completed A 24-week, Phase III, open-label, non-comparative, multi-center study to evaluate efficacy and safety of GSK1278863 in Japanese hemodialysis subjects with anemia associated with chronic kidney disease who are not taking erythropoiesis stimulating agents



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.